ATE311886T1 - Verwendung einer zusammensetzung enthaltend 5- androsten-3beta,17alpha-diol - Google Patents

Verwendung einer zusammensetzung enthaltend 5- androsten-3beta,17alpha-diol

Info

Publication number
ATE311886T1
ATE311886T1 AT03014193T AT03014193T ATE311886T1 AT E311886 T1 ATE311886 T1 AT E311886T1 AT 03014193 T AT03014193 T AT 03014193T AT 03014193 T AT03014193 T AT 03014193T AT E311886 T1 ATE311886 T1 AT E311886T1
Authority
AT
Austria
Prior art keywords
17alpha
androsten
3beta
diol
composition containing
Prior art date
Application number
AT03014193T
Other languages
English (en)
Inventor
Roger M Loria
Original Assignee
Roger M Loria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roger M Loria filed Critical Roger M Loria
Application granted granted Critical
Publication of ATE311886T1 publication Critical patent/ATE311886T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03014193T 1996-04-11 1997-04-10 Verwendung einer zusammensetzung enthaltend 5- androsten-3beta,17alpha-diol ATE311886T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1504296P 1996-04-11 1996-04-11
US1898596P 1996-06-04 1996-06-04

Publications (1)

Publication Number Publication Date
ATE311886T1 true ATE311886T1 (de) 2005-12-15

Family

ID=26686886

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97920244T ATE243518T1 (de) 1996-04-11 1997-04-10 5-androsten 3-beta, 17-alpha diol als tumorwachstumshemmer
AT03014193T ATE311886T1 (de) 1996-04-11 1997-04-10 Verwendung einer zusammensetzung enthaltend 5- androsten-3beta,17alpha-diol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT97920244T ATE243518T1 (de) 1996-04-11 1997-04-10 5-androsten 3-beta, 17-alpha diol als tumorwachstumshemmer

Country Status (8)

Country Link
EP (1) EP0925064B1 (de)
JP (1) JP2000508643A (de)
AT (2) ATE243518T1 (de)
DE (2) DE69723087T2 (de)
DK (1) DK0925064T3 (de)
ES (2) ES2202606T3 (de)
PT (1) PT925064E (de)
WO (1) WO1997037662A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1362591T3 (da) * 1996-04-11 2006-04-10 Roger M Loria Anvendelse af en sammensætning indeholdende 5-androsten-3beta, 17alfa-diol
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
WO2001023405A2 (en) 1999-09-30 2001-04-05 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
AU2001241779A1 (en) 2000-02-25 2001-09-03 Hollis-Eden Pharmaceuticals, Inc. Method of treatment of prostate cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US5461042A (en) * 1988-12-30 1995-10-24 Loria; Roger M. Regulation of the immune system
US5206008A (en) * 1991-04-15 1993-04-27 Virginia Commonwealth University Enhancement of immune response
US5478566A (en) * 1993-09-29 1995-12-26 Loria; Roger M. Stimulation of cytokine production

Also Published As

Publication number Publication date
EP0925064B1 (de) 2003-06-25
EP0925064A4 (de) 2001-11-07
JP2000508643A (ja) 2000-07-11
DK0925064T3 (da) 2003-10-20
ES2202606T3 (es) 2004-04-01
DE69723087T2 (de) 2004-05-06
WO1997037662A1 (en) 1997-10-16
ATE243518T1 (de) 2003-07-15
ES2254828T3 (es) 2006-06-16
PT925064E (pt) 2003-11-28
DE69723087D1 (de) 2003-07-31
DE60308917D1 (de) 2006-11-16
DE60308917T2 (de) 2006-12-28
EP0925064A1 (de) 1999-06-30

Similar Documents

Publication Publication Date Title
IL87885A (en) Pharmaceutical compositions having antiprogestational and anti-estrogenic activities for the treatment of hormone- dependent tumors
UA66417C2 (en) Recombinant adenovirus affecting canines, pharmaceutical composition
AU644610B2 (en) Synergistic microbicidal combinations
AU587004B2 (en) Heat-curable silicone compositions, use thereof and stabilizer therefor
ES8606289A1 (es) Un procedimiento para la preparacion de piridazinaminas.
CA2075060A1 (en) Novel vehicle gases and their use in medical preparations
EP0247167A4 (de) Hydroxy- und aminothiazolyl-benzodiazinonverbindungen, kardiotonische mittel, die diese enthalten und verwendungen.
EG18379A (en) Novel pharmacological compounds
EP0357675A4 (en) Pyridooxazinone-pyridone compounds, cardiotonic compositions including the same, and their uses
ES8203375A1 (es) Procedimiento de preparar triazoloquinoxalin-4-onas substi- tuidas antihipertensoras
AU570328B2 (en) Solid medicament formulations containing dihydropyridines
DE60308917D1 (de) Verwendung einer Zusammensetzung enthaltend 5-Androsten-3beta,17alpha-diol
EP0177153A3 (en) Interferon-cyclaradine combination
IT8419730A0 (it) Procedimento per la trasformazione quantitativa di teicoplanina a2fattore 1 in teicoplanina a2fattore 3.
AU6738587A (en) Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses
DE68911132D1 (de) Hematopoietische kolonien stimulierende faktoren zur verbesserung des lipoprotein/cholesterin-profils.
ES8701491A1 (es) Procedimiento para la preparacion de substancias secas obte-nibles por liofilizacion
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
IL97801A0 (en) Oligonucleotides,methods for in vitro tissue cell culture using the same and cosmetic compositions containing the same
CA2252110A1 (en) 5-androstene 3.beta.,17.alpha. diol as an inhibitor of tumor growth
EP0598269A3 (en) Apparatus for the culture of living cells and tissues.
PL257772A1 (en) An insecticide
UA6775A (uk) Склад зігрівального засобу для нашкірних аплікацій

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1362591

Country of ref document: EP

REN Ceased due to non-payment of the annual fee